Akers Biosciences Inc. (Nasdaq: AKER) received an initial order for its rapid cholesterol self-test from First Check Diagnostics sending the stock price up 95 cents to close at $2.35.
Akers Biosciences receives first order
March 28, 2017 at 16:57 PM EDT
